Drug to Control of Serum Phosphorus Sevelamer Carbonate Tablet 800mg
Basic Info
Model No.: DAWA1435
Product Description
Model NO.: DAWA1435 Usage Mode: For oral administration Shape: Tablet Pharmaceutical Technology: Chemical Synthesis Specifications: 800mg Trademark: NANOMAX Specification: GMP/WHO GMP/EURO GMP HS Code: 2941909000 Application: Internal Medicine State: Solid Type: Biological Products Name: Sevelamer Carbonate Tablet, Packing: 30tabs/Bottle Transport Package: 30tabs/Bottle Origin: France
Sevelamer Carbonate Tablet,
Dosage and Administration
INDICATIONS AND USAGE
Sevelamer carbonate is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
DOSAGE AND ADMINISTRATION
Starting dose of sevelamer carbonate is 0.8 or 1.6 grams administered orally three times per day with meals.
Titrate by 0.8 g per meal in two week intervals as needed to obtain serum phosphorus target (3.5 to 5.5 mg/dL).
Switch gram-for-gram among sevelamer formulations. Further titration may be necessary to achieve desired phosphorus levels.
DOSAGE FORMS AND STRENGTHS
Tablets: 800 mg
Powder: 0.8 g and 2.4 g packet
CONTRAINDICATIONS
Bowel obstruction.
WARNINGS AND PRECAUTIONS
Serious cases of dysphagia, bowel obstruction, and perforation have been associated with sevelamer use, some requiring hospitalization and surgery.
ADVERSE REACTIONS
Most of the safety experience is with sevelamer tablets. The most frequently occurring adverse reactions in a short term study with sevelamer carbonate tablets (8-week cross-over) study were: nausea (3%) and vomiting (3%). In a short term study of sevelamer carbonate powder, adverse events were similar to those reported for sevelamer carbonate tablets. In long-term studies with sevelamer hydrochloride, which contains the same active moiety as sevelamer carbonate, the most common adverse events included: vomiting (22%), nausea (20%), diarrhea (19%), dyspepsia (16%), abdominal pain (9%), flatulence (8%) and constipation (8%).
Cases of fecal impaction and, less commonly, ileus, bowel obstruction and bowel perforation have been reported. Contact us if you need more details on Sevelamer. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Carbonate、Tablet. If these products fail to match your need, please contact us and we would like to provide relevant information.
| Name | Sevelamer Carbonate Tablet, |
| Strength | 800mg |
| Package | 30tabs/bottle |
Sevelamer Carbonate Tablet,
Dosage and Administration
INDICATIONS AND USAGE
Sevelamer carbonate is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.
DOSAGE AND ADMINISTRATION
Starting dose of sevelamer carbonate is 0.8 or 1.6 grams administered orally three times per day with meals.
Titrate by 0.8 g per meal in two week intervals as needed to obtain serum phosphorus target (3.5 to 5.5 mg/dL).
Switch gram-for-gram among sevelamer formulations. Further titration may be necessary to achieve desired phosphorus levels.
DOSAGE FORMS AND STRENGTHS
Tablets: 800 mg
Powder: 0.8 g and 2.4 g packet
CONTRAINDICATIONS
Bowel obstruction.
WARNINGS AND PRECAUTIONS
Serious cases of dysphagia, bowel obstruction, and perforation have been associated with sevelamer use, some requiring hospitalization and surgery.
ADVERSE REACTIONS
Most of the safety experience is with sevelamer tablets. The most frequently occurring adverse reactions in a short term study with sevelamer carbonate tablets (8-week cross-over) study were: nausea (3%) and vomiting (3%). In a short term study of sevelamer carbonate powder, adverse events were similar to those reported for sevelamer carbonate tablets. In long-term studies with sevelamer hydrochloride, which contains the same active moiety as sevelamer carbonate, the most common adverse events included: vomiting (22%), nausea (20%), diarrhea (19%), dyspepsia (16%), abdominal pain (9%), flatulence (8%) and constipation (8%).
Cases of fecal impaction and, less commonly, ileus, bowel obstruction and bowel perforation have been reported. Contact us if you need more details on Sevelamer. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Carbonate、Tablet. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : Medical Antibiotics
Email to this supplier
Other Products
Hot Products
High Quality 200mg Amiodarone Hydrochloride TabletsLarge Stock Whiten Skin Monobenzone CreamGeneral Medicine Omeprazole 20mg Injection for Gastrohelcosis and Stomach AcidGeneral Medicine Ceftriaxone Sodium InjectionPharmaceutical Chlornitromycin CAS 56-75-7 Chloroamphenicol for Veterinary Use (Oap-014)Ready Stock Skin Whitening Anti-Aging Vitamin C InjectionCAS 57-85-2 Injectable Steroid Compound Testosterone PropionateHigh Quality Usnic Acid with High PurityMuscle Builder Weight Loss Homebrew Steroids Testosterone SustanonFDA Approved Curative Antimalarial ArtemisininMedicine Treating Brain Injury Citicoline Sodium InjectionProtease Alpha Chymolase for Inflammatory EdemaGeneral Medicine Medroxyprogesterone Acetate InjectionAmikacin Injection General Medicine DrugsSkin Whitening Gsh Personal Care Glutathione InjectionBody Slimming Fitness Lose Weight Weight Loss L-Carnitine Injection2.0g/5ml